| Literature DB >> 2463971 |
Y X Zhang1, S J Stewart, H D Caldwell.
Abstract
Monoclonal antibodies exhibiting Chlamydia trachomatis serovar specificity (serovar A, B-Ba, or C) and serogroup specificity (B, intermediate, or C serogroup) were produced and characterized. These antibodies reacted with the major outer membrane protein, recognized epitopes located at the chlamydial cell surface, and passively neutralized chlamydial toxicity for mice. The antibodies should be useful reagents for defining the molecular structure of these protective epitopes, a necessary step toward the development of a subunit or recombinant C. trachomatis vaccine.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2463971 PMCID: PMC313145 DOI: 10.1128/iai.57.2.636-638.1989
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441